Related Experiment Video
Updated: May 11, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
IgA vasculitis after COVID-19: a case-based review
Dorota Suszek1, Anna Grzywa-Celińska2, Justyna Emeryk-Maksymiuk3
1Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland. suszekdorota@wp.pl.
IgA-associated vasculitis (IgAV), or Henoch-Schönlein purpura (HSP), can develop after infections. This case suggests SARS-CoV-2 may trigger HSP in adults, highlighting potential differences from pediatric cases.
Area of Science:
- Immunology
- Rheumatology
- Infectious Diseases
Background:
- IgA-associated vasculitis (IgAV), also known as Henoch-Schönlein purpura (HSP), is a small vessel vasculitis.
- It is the most common systemic vasculitis in children, often following infections.
- IgAV in adults is rare, poorly understood, and may have a different clinical course, particularly regarding renal complications.
Observation:
- A 58-year-old woman presented with classic HSP symptoms: palpable purpura, arthritis, and hematuria.
- Her condition followed a respiratory tract infection.
- COVID-19 infection was confirmed through serological testing (IgM and IgG antibodies).
Findings:
- This case report suggests a potential link between SARS-CoV-2 infection and the development of HSP in an adult.
- The patient's symptoms resolved promptly with low-dose steroid treatment.
- Adult IgAV may present differently than pediatric IgAV, with a higher risk of kidney involvement.
Implications:
- The findings suggest SARS-CoV-2 as a potential trigger for IgA-associated vasculitis in adults.
- Further research is needed to understand the specific mechanisms and long-term outcomes of COVID-19-associated HSP in adults.
- This case underscores the importance of considering viral triggers in adult-onset vasculitis and monitoring for renal complications.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis I: Introduction